Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
暂无分享,去创建一个
E. Braunwald | C. Cannon | J. Loscalzo | R. Becker | B. Sobel | J. Scharfstein | D. Abendschein | L. A. Cupples | P. Eisenberg | D. George | B. Sobel | Jonathan Scharfstein | Christopher P. Cannon | E. Braunwald | L. Cupples | J. Loscalzo | Richard C. Becker | Paul R. Eisenberg | Joseph Loscalzo | Eugene Braunwald
[1] G. Ewald,et al. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. , 1995, Circulation.
[2] C. Cannon,et al. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. , 1994, Journal of the American College of Cardiology.
[3] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[4] U. Tebbe,et al. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. , 1993, Journal of the American College of Cardiology.
[5] M. J. Hursting,et al. Monoclonal antibodies specific for prothrombin fragment 1.2 and their use in a quantitative enzyme-linked immunosorbent assay. , 1993, Clinical chemistry.
[6] A. Stead,et al. Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. , 1993, Clinical Chemistry.
[7] D. Collen,et al. Plasma Fibrinopeptide A Levels in Patients With Acute Myocardial Infarction Treated With Alteplase: Correlation With Concomitant Heparin, Coronary Artery Patency, and Recurrent Ischemia , 1992, Circulation.
[8] P. Declerck,et al. Plasma levels of plasminogen activator inhibitor type 1, beta-thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase. , 1991, Blood.
[9] K. Mann,et al. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction. , 1990, Blood.
[10] A. Haeberli,et al. Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator. , 1989, Circulation.
[11] S. Butman,et al. Fibrin Metabolism in Patients with Acute Myocardial Infarction During and After Treatment with Tissue-Type Plasminogen Activator , 1988, Thrombosis and Haemostasis.
[12] K. Friedman,et al. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. , 1988, Blood.
[13] H. Pelzer,et al. Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay , 1988, Thrombosis and Haemostasis.
[14] A. Jaffe,et al. Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. , 1987, Journal of the American College of Cardiology.
[15] A. Jaffe,et al. Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis. , 1986, Journal of the American College of Cardiology.
[16] A. Jaffe,et al. Fibrinopeptide A: a marker of acute coronary thrombosis. , 1985, Circulation.
[17] B. Kudryk,et al. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin. , 1983, Molecular immunology.
[18] S. Frebelius,et al. Rapid radioimmunoassay of human fibrinopeptide A - removal of cross-reacting fibrinogen with bentonite. , 1980, Thrombosis research.
[19] S. Niewiarowski,et al. Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation , 1977 .
[20] V. Vinciguerra,et al. Ultrastructural cytochemical analysis of blastic transformation of chronic myelocytic leukemia. , 1977, Blood.